Samuel Lentz to Nucleic Acid Synthesis Inhibitors
This is a "connection" page, showing publications Samuel Lentz has written about Nucleic Acid Synthesis Inhibitors.
Connection Strength
0.013
-
Plaxe SC, Blessing JA, Olt G, Husseinzadah N, Lentz SS, DeGeest K, Valea FA. A phase II trial of pyrazoloacridine (PZA) in squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study. Cancer Chemother Pharmacol. 2002 Aug; 50(2):151-4.
Score: 0.013